Translational Development Acquisition TDAC
NASDAQ TDAC
$10.84 -0.01 (-0.09%)
At close: Aug 20, 2026 · 4:00 PM EDT

Translational Development Acquisition (TDAC) Retained Earnings (2023 - 2026)

Translational Development Acquisition's (TDAC) quarterly Retained Earnings came in at -$6.8 million in Q1 2026, down 14.77% YoY from -$8.0 million in Q1 2025, and down 4.3% on a QoQ basis from -$6.5 million in Q4 2025.

Translational Development Acquisition (TDAC) Retained Earnings (2023 - 2026) Analysis & Trends

Translational Development Acquisition (TDAC) has 4 years of Retained Earnings data on file, last reported at -$6.8 million in Q1 2026.

  • Quarterly Retained Earnings fell 14.77% year-over-year to -$6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 14.77% YoY) and the FY2025 annual result came in at -$6.5 million, down 16.87% from the prior year.
  • Retained Earnings retreated to -$6.8 million in Q1 2026, from -$6.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $24534.0 in Q4 2023 to a low of -$6.8 million in Q1 2026.
  • A 4-year average of -$5.3 million and a median of -$6.2 million in 2025 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2024 — Retained Earnings sank 22917.46% — and 2026, when it fell 14.77%.
  • Tracing TDAC's Retained Earnings over 4 years: stood at $24534.0 in 2023, then slumped by 22917.46% to -$5.6 million in 2024, then decreased by 16.87% to -$6.5 million in 2025, then dropped by 4.3% to -$6.8 million in 2026.
  • The last three Retained Earnings figures came in at -$6.8 million (Q1 2026), -$6.5 million (Q4 2025), and -$6.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - -10.94 Mn
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -17.93 Mn
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - -152,213.00
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -16.30 Mn
5 Aldel Financial 397.49 Mn 397.49 Mn - 315,419.00
6 Gores Holdings X 381.05 Mn 380.85 Mn - -31.03 Mn
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -34.15 Mn
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - -9.48 Mn
9 Berto Acquisition 313.96 Mn 313.81 Mn - -13.81 Mn
10 Translational Development Acquisition 182.66 Mn 182.57 Mn - -7.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.82 Mn
Dec 31, 2025 -6.54 Mn
Sep 30, 2025 -6.38 Mn
Jun 30, 2025 -6.17 Mn
Mar 31, 2025 -5.95 Mn
Dec 31, 2024 -5.60 Mn
Dec 31, 2023 24,534.00